Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report)’s stock price traded up 7% during trading on Tuesday . The stock traded as high as $20.63 and last traded at $20.83. 525,396 shares changed hands during mid-day trading, a decline of 91% from the average session volume of 5,702,871 shares. The stock had previously closed at $19.46.
Analyst Upgrades and Downgrades
Several equities research analysts have recently commented on the stock. Barclays reduced their price target on shares of Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating for the company in a report on Thursday, May 28th. Weiss Ratings downgraded shares of Bath & Body Works from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Tuesday, June 2nd. UBS Group cut their price objective on shares of Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 20th. Piper Sandler began coverage on shares of Bath & Body Works in a research report on Friday, May 15th. They issued a “neutral” rating and a $20.00 price objective on the stock. Finally, Citigroup downgraded shares of Bath & Body Works from a “buy” rating to a “neutral” rating and lifted their price objective for the stock from $21.00 to $25.00 in a research report on Tuesday, February 17th. Three equities research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $21.93.
View Our Latest Analysis on BBWI
Bath & Body Works Stock Up 7.7%
Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, topping analysts’ consensus estimates of $0.29 by $0.03. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The business had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.36 billion. During the same quarter in the previous year, the firm earned $0.49 earnings per share. The company’s revenue was down 3.2% on a year-over-year basis. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, equities analysts anticipate that Bath & Body Works, Inc. will post 2.62 earnings per share for the current year.
Bath & Body Works Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 19th. Stockholders of record on Friday, June 5th will be paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 3.8%. The ex-dividend date is Friday, June 5th. Bath & Body Works’s dividend payout ratio (DPR) is presently 22.47%.
Institutional Investors Weigh In On Bath & Body Works
A number of institutional investors have recently added to or reduced their stakes in BBWI. Parallel Advisors LLC lifted its stake in Bath & Body Works by 35.5% in the 1st quarter. Parallel Advisors LLC now owns 2,570 shares of the company’s stock valued at $48,000 after buying an additional 673 shares in the last quarter. Caerus Investment Advisors LLC purchased a new position in Bath & Body Works in the 1st quarter valued at about $208,000. Segall Bryant & Hamill LLC lifted its stake in Bath & Body Works by 17.7% in the 1st quarter. Segall Bryant & Hamill LLC now owns 327,089 shares of the company’s stock valued at $6,107,000 after buying an additional 49,100 shares in the last quarter. Bank of America Corp DE lifted its stake in Bath & Body Works by 26.2% in the 1st quarter. Bank of America Corp DE now owns 2,050,414 shares of the company’s stock valued at $38,281,000 after buying an additional 425,248 shares in the last quarter. Finally, South Dakota Investment Council lifted its stake in Bath & Body Works by 4.2% in the 1st quarter. South Dakota Investment Council now owns 1,756,048 shares of the company’s stock valued at $32,785,000 after buying an additional 71,255 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.
About Bath & Body Works
Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.
Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.
Read More
- Five stocks we like better than Bath & Body Works
- Is Lennar Finally Turning the Corner After Its Housing Slump?
- AI Memory Demand Has Turned These 5 S&P 500 Stocks Into Market Leaders
- 3 Dividend Kings With Income, Stability, and a Possible Catalyst
- Plot Twist: How the $110B Paramount-Warner Deal Rewrites Media
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
